-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Product Insights
Gouty Arthritis (Gout) – Drugs In Development, 2023
Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Drugs In Development, 2023’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gouty Arthritis (Gout), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Musculoskeletal Inflammation – Drugs In Development, 2023
Global Markets Direct’s, ‘Musculoskeletal Inflammation - Drugs In Development, 2023’, provides an overview of the Musculoskeletal Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Musculoskeletal Inflammation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Clostridium Difficle Tests Market Report Overview The clostridium difficle tests market size was valued at $172.1 million in 2023. Clostridium difficile tests are carried out to diagnose the bacterium, commonly known as C. diff, which is a major cause of serious diarrheal infections and may also cause colon cancer. Clostridium Difficle Tests Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on the Clostridium Difficle Tests Market Forecast, Download a Free Sample Report The clostridium difficle tests...
-
Product Insights
Injectable Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Injectable Drug Delivery Pipeline Market Report Overview Injectable drug delivery devices help administer a drug into a patient’s blood. The Injectable Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Sustained Release Injectable...
-
Sector Analysis
Acrylonitrile-Butadiene-Styrene (ABS) Industry Capacity and Capital Expenditure Forecasts with Details of Active and Planned Plants to 2027
Acrylonitrile Butadiene Styrene Industry Overview Acrylonitrile-Butadiene-Styrene (ABS) capacity was 14.22 million tonnes per annum (mtpa) in 2022 and will register an AAGR of more than 6% during 2022 - 2027. China, South Korea, Taiwan, the US, and Japan are the key countries accounting for majority of the total ABS capacity in the world. ABS Capacity Outlook, 2022-2027 (mtpa) Buy Full Report for More Insights on ABS Capacity and Capex Market Forecast, Download a Free Report Sample The ABS capacity and capital expenditure...
-
Product Insights
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Meningitis Pipeline Drugs Market Report Overview Meningitis is the inflammation caused by viruses and bacteria on the protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening. Viral meningitis is not life-threatening and the people affected with this can be cured and recover quickly, but bacterial meningitis...
-
Product Insights
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Poliomyelitis Pipeline Drugs Market Report Overview Polio is a highly infectious disease caused by a virus. It invades the nervous system and causes total paralysis in a matter of hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis pipeline drugs market research report provides comprehensive information on the Poliomyelitis targeted therapeutics, complete with analysis by indications, stage of development,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ERX-963
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ERX-963 Drug Details ERX-963 is under development for the treatment of myotonic dystrophy type...
-
Product Insights
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol intake, injury to joints, long-standing kidney disease, and high intake of foods rich in purines. The Gouty Arthritis (Gout)...